flutamide has been researched along with technetium in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Benny, PD; Bucar, DK; Macgillivray, LR; Moore, AL | 1 |
Alonso, O; Cardoso, ME; Carrau, G; Coppe, F; Daher, G; Decuadra, P; Delfino, A; Gamenara, D; Giglio, J; Mesa, JM; Rey, A; Tejería, E; Terán, M; Zeni, M | 1 |
2 other study(ies) available for flutamide and technetium
Article | Year |
---|---|
"Click" labeling strategy for M(CO)(3) (M = Re, (99m)Tc) prostate cancer targeted flutamide agents.
Topics: Crystallography, X-Ray; Flutamide; Humans; Isotope Labeling; Male; Molecular Conformation; Prostatic Neoplasms; Radionuclide Imaging; Radiopharmaceuticals; Receptors, Androgen; Rhenium; Technetium; Triazoles | 2010 |
Development and Evaluation of
Topics: Diagnostic Imaging; Flutamide; Humans; Male; Organotechnetium Compounds; Radiopharmaceuticals; Receptors, Androgen; Technetium | 2023 |